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Structurally distinct, self-templating prion ‘‘strains’’
can encode distinct phenotypes and amplify at
different rates depending upon the environment.
Indeed, prion strain ensembles can evolve in
response to environmental challenges, which makes
them highly challenging drug targets. It is not under-
stood how the proteostasis network amplifies one
prion strain at the expense of another. Here, we
demonstrate that Hsp104 remodels the distinct inter-
molecular contacts of different synthetic Sup35 prion
strains in a way that selectively amplifies prions en-
coding strong [PSI+] and simultaneously eliminates
prions encoding weak [PSI+]. Hsp104 has reduced
ability to fragment prions encoding weak [PSI+], but
readily converts them to nontemplating forms. By
contrast, Hsp104 readily fragments prions encoding
strong [PSI+], but has reduced ability to eliminate
their infectivity. Thus, we illuminate direct mecha-
nisms underpinning how the proteostasis network
can drive prion strain selection.
INTRODUCTION
Prions are infectious amyloid structures that typically exist
as ensembles of multiple structurally distinct, self-templating
‘‘strains’’, which can vary in chemical stability and confer distinct
phenotypes (Colby and Prusiner, 2011; Krishnan and Lindquist,
2005; Roberts et al., 2009; Tanaka et al., 2004, 2006; Tessier
and Lindquist, 2009). As self-replicating structures, prions are
hypothesized to be units of selection, i.e., are subject to natural
selection (Li et al., 2010; Shorter, 2010; Shorter and Lindquist,
2005; Weissmann, 2012). Thus, natural selection acting at the
unfamiliar level of self-templating prions inescapably enriches
or depletes various prion strains from strain populations depend-
ing upon their conformational fitness, i.e., ability to self-replicate
their specific strain conformation under the prevailing environ-
mental conditions (Collinge and Clarke, 2007; Duennwald and
Shorter, 2010; Ghaemmaghami et al., 2009, 2011; Li et al.,
2010; Roberts et al., 2009; Shorter, 2010; Weissmann, 2012).
This microevolutionary process can give rise to conflict between
levels of selection (Shorter, 2010). Thus, prions can be detri-1400 Chemistry & Biology 19, 1400–1410, November 21, 2012 ª2012mental to the individual as with diverse infectious conformers
of the mammalian prion protein (PrP), which are connected
with fatal neurodegenerative diseases, including Creutzfeldt-
Jakob disease (Colby and Prusiner, 2011; Collinge and Clarke,
2007; Weissmann, 2012). Similarly, in yeast, some Sup35 and
Ure2 prion strains can be detrimental (McGlinchey et al., 2011).
However, in other circumstances, including diverse stress con-
ditions, Sup35 prions and other yeast prions commonly found
in wild yeast confer selective advantages and promote the evolu-
tion of new traits (Halfmann et al., 2010, 2012; Shorter and Lind-
quist, 2005; Suzuki et al., 2012; True and Lindquist, 2000).
Dramatic examples of prion strain selection are provided by
the emergence of drug-resistant strains of PrP and Sup35 in
response to specific small molecules (Ghaemmaghami et al.,
2009; Li et al., 2010; Roberts et al., 2009; Shorter, 2010). For
example, the green tea polyphenol, Epigallocatechin-3-gallate
(EGCG), selects for EGCG-resistant strains of Sup35 in vitro
and in vivo (Duennwald and Shorter, 2010; Roberts et al.,
2009). Swainsonine selects for drug-resistant mammalian prions
in cell culture (Li et al., 2010) and quinacrine selects for drug-
resistant mammalian prions in mice (Ghaemmaghami et al.,
2009). The ability of prion strain ensembles to evolve in response
to environmental challenges created by small molecules makes
them challenging drug targets (Shorter, 2010; Weissmann,
2012). Thus, it is critical to understand the endogenous selection
pressures within cells and tissues that drive the amplification of
one prion strain at the expense of another.
Strain selection phenomena occur in response to the imme-
diate environment. Thus, components of the proteostasis
network must play a critical role in strain selection (Balch et al.,
2008; Ghaemmaghami et al., 2011; Li et al., 2010). However, little
is known or understood about the direct mechanisms by which
the proteostasis network selects for or against different prion
strains (Collinge and Clarke, 2007; Li et al., 2010; Shorter,
2010). Indeed, the mechanistic interplay between molecular
chaperones, prion-remodeling factors, and different amyloid or
prion strains is poorly understood at the biochemical and bio-
logical level. Here, we exploit the [PSI+] prion protein, Sup35,
to address this issue. Using a minimal system comprised of
pure components, we have investigated how various synthetic
prion strain ensembles of the translation termination factor,
Sup35, which encode different variants of the yeast prion
[PSI+] (Roberts et al., 2009; Shorter, 2010; Shorter and Lindquist,
2005; Tanaka et al., 2004, 2006), evolve when challenged with
different levels of the prion-remodeling factor, Hsp104.Elsevier Ltd All rights reserved
Figure 1. Chemical and Biological Proper-
ties of Synthetic NM4, NM25, and NM37
Prions
Sup35 is composed of a C-terminal GTPase
domain (amino acids 254–685, black) that confers
translation termination activity, a highly charged
middle domain (M, amino acids 124–253, dark
gray) and a prionogenic N-terminal domain (N,
amino acids 1–123, light gray) enriched in gluta-
mine, asparagine, tyrosine and glycine. Within N,
prion recognition elements termed the ‘‘Head’’
(red) and ‘‘Tail’’ (green), which flank a ‘‘Central
Core’’ (blue), play important roles in prionogenesis.
Prion recognition elements within N make homo-
typic intermolecular contacts such that Sup35
prions appear to be maintained by an alternating
sequence of Head-to-Head (red) and Tail-to-Tail
(green) contacts. The Central Core (blue) is
sequestered by intramolecular contacts. Different
prion strains can form depending on the environ-
mental conditions. Thus, the NM4 prion ensemble
forms at 4C, the NM25 prion ensemble forms at
25C, and the NM37 prion ensemble forms at
37C. Note that on average the Central Core (blue)
and Tail (green) are comprised of different amino
acids in the NM4, NM25, and NM37 prion
ensembles. On average, NM25 and NM37 prions have an extended central core and have a higher melting temperature in 2% SDS than NM4. Transformation of
NM25 or NM37 prions into [psi] cells yields mostly weak [PSI+], whereas transformation of NM4 prions into [psi] cells yields mostly strong [PSI+]. These mixed
distributions of weak and strong [PSI+] indicate that NM4, NM25, and NM37 are in fact complex mixtures of multiple different prion structures, rather than a single
pure strain. It is also important to note that the atomic structures of Sup35 prion strains remain unknown and several models (including the models presented in
this figure) have been advanced (Tessier and Lindquist, 2009).
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Hsp104 Drives Sup35 Prion Strain SelectionHsp104 is a hexameric AAA+ ATPase, which is critical for the
propagation of the vast majority of yeast prions (Alberti et al.,
2009; Halfmann et al., 2012; Shorter and Lindquist, 2005). How
Hsp104 directly affects different Sup35 prion strains is unknown.
To address this issue, we exploited pure NM, the prion domain of
Sup35 (Figure 1). N-terminal and Middle domains of Sup35 (NM)
spontaneously assembles into different prion strain ensembles
at different temperatures. Thus, prions within strain ensembles
formed by synthetic NM at 4C, termed NM4, possess on
average a shorter, less stable amyloid core (Tm54C) with dis-
tinctive intermolecular contacts (Figure 1). By contrast, synthetic
NM prion strain ensembles formed at 25C or 37C, termed
NM25 and NM37, harbor prions that possess, on average,
longer, more stable amyloid cores (Tm81C for NM25 and
Tm86C for NM37) with intermolecular contacts distinct to
NM4 (Krishnan and Lindquist, 2005; Roberts et al., 2009; Tanaka
et al., 2004, 2006; Tessier and Lindquist, 2007, 2009; Toyama
et al., 2007; Figure 1). When transformed into [psi] yeast cells
(which lack Sup35 prions), synthetic NM4 prions confer mostly
strong [PSI+] (strong [PSI+]:weak [PSI+]3:1), whereas NM25
and NM37 prions confer mostly weak [PSI+] (strong [PSI+]:weak
[PSI+]1:3 for NM25 and 1:5.7 for NM37; Krishnan and Lind-
quist, 2005; Tanaka et al., 2004, 2006; Figure 1). These mixed
distributions of weak and strong [PSI+] indicate that NM4,
NM25, and NM37 are complex mixtures of multiple different
prion strain structures, rather than a single pure strain. Here,
‘‘strength’’ refers to the magnitude of the translation termination
defect caused by depletion of soluble, functional Sup35 by self-
templating Sup35 prions (Derkatch et al., 1996; Tanaka et al.,
2004). Thus, NM4 prions typically convert more soluble Sup35
to the prion state in vivo than NM25 or NM37 prions (TanakaChemistry & Biology 19, 1400–141et al., 2004, 2006). It has been suggested that the increased
fragility of NM4 compared to NM25 and NM37 enables more
facile fragmentation by Hsp104, which generates more fiber
ends competent to convert soluble Sup35 to the prion state
(Tanaka et al., 2006). However, to the best of our knowledge,
this hypothesis has never been tested directly with pure
components.
Here, we establish for the first time, to our knowledge, the
direct consequences of Hsp104-catalzyed remodeling on the
NM4, NM25, and NM37 ensembles. We define unanticipated
differences in the way Hsp104 disrupts the intermolecular
contacts of different Sup35 prion strains. This type of mecha-
nistic insight is only possible with Sup35 prions where the
intermolecular contacts can be tracked using fluorescence
tools that are not yet available for other prions (Krishnan and
Lindquist, 2005; Roberts et al., 2009; Wang et al., 2008). We
have reconstituted and deciphered the first direct mechanisms
by which components of the proteostasis network can drive
‘‘protein only’’ positive selection of a specific prion strain. Impor-
tantly, we verify our findings in vivo. Thus, we uncover that
Hsp104 directly drives strain selection events that favor prions
encoding strong [PSI+].
RESULTS
Hsp104 More Readily Remodels NM4 Prions
than NM25 and NM37
First, we assessed the prion-remodeling activity of Hsp104
against NM4, NM25, and NM37 prions in the presence of Ssa1
(an Hsp70) and Sis1 (an Hsp40) because these molecular chap-
erones contribute to [PSI+] propagation in vivo (Bagriantsev0, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1401
Figure 2. Hsp104 More Readily Remodels
NM4 Prions than NM25 and NM37
(A–D) NM4, NM25, or NM37 (2.5 mM monomer)
were incubated with increasing concentrations of
Hsp104 (0.001–25 mM) in the presence (A and B) or
absence (C and D) of Ssa1 (2.5 mM) and Sis1
(2.5 mM) for 60 min at 25C. ThT fluorescence (A
and C) or SDS resistance (B and D) were used to
assess prion remodeling. The EC50 and Hill slope
(n) are indicated next to each curve. Values
represent means ± SEM (n = 2–3).
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Hsp104 Drives Sup35 Prion Strain Selectionet al., 2008; Higurashi et al., 2008; Hines et al., 2011; Tipton et al.,
2008). Moreover, although Ssa1 and Sis1 are not absolutely
required for Hsp104 to remodel Sup35 prions in vitro, they can
enhance Hsp104 amyloid-remodeling activity (Duennwald
et al., 2012; Shorter and Lindquist, 2004, 2006, 2008; Sweeny
and Shorter, 2008). Thus, we exposed different synthetic NM
prion strain ensembles to increasing concentrations of Hsp104
in the presence of a constant amount of Hsp70 (Ssa1) and
Hsp40 (Sis1). We measured prion remodeling using the
amyloid-diagnostic dye, Thioflavin-T (ThT), which exhibits en-
hanced fluorescence upon binding cross-beta amyloid structure
(Chernoff et al., 2002). Under our conditions, in the absence of
Hsp104 no prion remodeling is observed. Hsp104 more readily
remodels NM4 prions than NM25 and NM37 (Figure 2A). The
EC50 (the half-maximal effective concentration) of Hsp104 was
0.06 mM for NM4, 0.12 mM for NM25, and 0.35 mM for
NM37. Very similar EC50 values were obtained when remodel-
ing was measured by the amount of SDS-insoluble NM
(SDS-resistance) instead of ThT fluorescence as a measure of
fiber integrity (Chernoff et al., 2002; Figure 2B). The apparent
Hill slope (n) became progressively steeper upon moving from
NM4 (n2.7) to NM25 (n4.6) to NM37 (n9.8; Figure 2A).
These data indicate that Hsp104 functions with increased
co-operativity to remodel more stable NM prions, which se-
quester more primary sequence in cross-beta structure (Fig-
ure 1). Thus, to remodel NM37 prions Hsp104 must function
with greater co-operativity than to remodel NM4 prions (Figures
2A and 2B).
In the absence of Ssa1 and Sis1, Hsp104 promoted similar
levels of prion remodeling (Figures 2C and 2D). However, for
each strain ensemble the Hsp104 EC50 determined by ThT
fluorescence was slightly elevated to 0.07 mM for NM4,
0.16 mM for NM25, and 0.64 mM for NM37 (Figure 2C), and
similar values were obtained via SDS-resistance (Figure 2D).
By contrast, the apparent Hill slopes were very similar in the
presence or absence of Ssa1 and Sis1, which indicate that
Ssa1 and Sis1 do not affect Hsp104 co-operativity (Figures 2C1402 Chemistry & Biology 19, 1400–1410, November 21, 2012 ª2012 Elsevier Ltd All rights rand 2D). The increase in EC50 was most
pronounced for NM37 (Figures 2A–2D).
Thus, Ssa1 and Sis1 are not absolutely
required for Sup35 prion remodeling by
Hsp104 (Duennwald et al., 2012; Shorter
and Lindquist, 2004, 2006, 2008), but
likely play a more important role for
Sup35 prions that encode weak [PSI+].
These findings are consistent with obser-vations that Sis1 depletion only partially impairs [PSI+] propaga-
tion in vivo and that weak [PSI+] strains are more sensitive to
Sis1 depletion than strong [PSI+] strains (Higurashi et al., 2008;
Hines et al., 2011; Tipton et al., 2008).
The reduced ability of Hsp104 to remodel NM37 and NM25
prions compared to NM4 (Figure 2) might reflect a reduced
binding affinity for NM37 and NM25 compared to NM4. Yet,
the Kd of Hsp104 for NM4, NM25, and NM37 was very similar
at 35, 30, and 33 nM respectively. Moreover, NM4, NM25,
and NM37 all bound similar amounts of Hsp104. Thus, some
aspect of NM37 and NM25 prion structure (e.g., increased local
stability of the cross-beta form adjacent to where Hsp104 initially
engages the prion) likely antagonizes Hsp104 remodeling
activity after initial binding.
Hsp104 More Readily Fragments NM4 Prions
than NM25 and NM37
To further define how Hsp104 remodels NM4, NM25, and NM37
prions we directly monitored the integrity of their intermolecular
prion contacts (Figure 1). To do so, we independently assembled
17 individual single cysteine NM variants labeled with pyrene
at different positions. These pyrene-labeled NM variants retain
wild-type assembly kinetics and infectivity, indicating that
pyrene does not significantly alter prion structure (Krishnan
and Lindquist, 2005; Roberts et al., 2009; Wang et al., 2008).
Upon intermolecular contact formation, pyrene molecules at
select positions, in the Head or Tail (Figure 1), form excimers
(excited-state dimers) that produce a strong red shift in fluores-
cence. Thus, excimer fluorescence reports on intermolecular
contact integrity (Krishnan and Lindquist, 2005; Roberts et al.,
2009; Wang et al., 2008).
We selected two Hsp104 concentrations to study fragmen-
tation of NM4, NM25, and NM37 strains based on the prion-
remodeling data in Figure 2. Thus, we selected a low concen-
tration (0.1 mM) at which Hsp104 effectively remodeled NM4,
but not NM25 or NM37 (Figure 2). We also assessed a high
concentration (1 mM) at which Hsp104 had maximal activityeserved
Figure 3. Hsp104 Preferentially Breaks NM4
Intermolecular Contacts at Low Concen-
trations, but Preferentially Disrupts NM25
and NM37 Intermolecular Contacts at High
Concentrations
NM proteins (5 mM) carrying pyrene labels at
the indicated single site were assembled at 4C,
25C, or 37C with agitation for 12 hr. Assembled
NM4, NM25, or NM37 (2.5 mM monomer) were
incubated with Hsp104 (0–1 mM) in the presence
or absence of Ssa1 (2.5 mM) and Sis1 (2.5 mM)
for 60 min at 25C. The ratio of excimer to
nonexcimer fluorescence (I465nm/I375nm) was then
determined.
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preformed pyrene-labeled NM4, NM25, or NM37 prions with
buffer or Ssa1 and Sis1 alone had no effect on prion contacts
(Figure 3). By contrast, addition of a low concentration (0.1 mM)
of Hsp104 readily disrupted both the Head (residues 21–38)
and Tail (residues 79–96) contacts of NM4 prions in the presence
or absence of Ssa1 and Sis1 (Figure 3). Thus, Hsp104 can
readily break intermolecular prion contacts, which are remark-
ably stable and resist external pulling forces of 250 pN (Dong
et al., 2010).
Likewise, in the presence or absence of Ssa1 and Sis1, low
concentrations of Hsp104 readily disrupted the Tail contacts
(residues 91–106) of NM25 prions. However, in contrast to
NM4, the Head contacts (residues 21–38) of NM25 prions were
more refractory to disruption by low concentrations of Hsp104
(Figure 3). This effect was even more pronounced for NM37
prions, where a low concentration of Hsp104 (0.1 mM) was
even less able to disrupt the Head (residues 21–38) and Tail
(residues 91–112) contacts (Figure 3). For NM37 prions, the
presence of Ssa1 and Sis1 was more critical, and enhanced
the ability of a low concentration of Hsp104 (0.1 mM) to disrupt
Tail contacts (Figure 3). These data suggest that Hsp104 more
readily fragments NM4 prions than NM25 prions, which in turn
are more readily fragmented than NM37 prions.
These data also indicate that propagation of strong [PSI+]
in vivo likely proceeds via Hsp104-catalyzed severing of both
Head and Tail prion contacts, as observed with NM4 prions
in vitro (Figure 3). By contrast, propagation of weak [PSI+] in vivo
likely proceeds via Hsp104-catalyzed severing of predominantly
the Tail contact, as observed with NM25 and NM37 prions (Fig-
ure 3). Moreover, these data suggest that at a low concentra-
tion (0.1 mM), Hsp104 can break the Tail contacts of NM25 and
NM37 prions (Figure 3) without causing large reductions in the
total amount of cross-beta structure as determined by ThT
fluorescence or SDS-resistance (Figures 2A–2D). Thus, prion
fragmentation (i.e., breakage of intermolecular contacts) can
be separated from prion remodeling (i.e., reductions in the
amount of cross-beta structure measured by ThT fluorescence
or SDS-resistance).
Electron microscopy (EM) confirmed that at this low concen-
tration (0.1 mM), Hsp104 fragmented networks of NM4 prions
more readily than NM25 or NM37 prions in the presence orChemistry & Biology 19, 1400–141absence of Ssa1 and Sis1 (Figure 4, compare conditions without
Hsp104 to those with 0.1 mM Hsp104). This increased fragmen-
tation of NM4 by Hsp104 is due to breakage of both Head and
Tail contacts (Figure 3), which yields more fiber ends able to
capture and convert nonprion forms of Sup35. The enhanced
severing of NM4 prions by Hsp104 helps explain why they
encode predominantly strong [PSI+] and why NM25 and NM37
prions encode predominantly weak [PSI+] in vivo.
High Levels of Hsp104 Convert NM25 and NM37
to Nontemplating Structures
Hsp104 overexpression cures weak [PSI+] more readily than
strong [PSI+] (Chernoff et al., 1995; Wegrzyn et al., 2001), yet
NM25 and NM37 were more refractory to Hsp104-catalyzed
remodeling than NM4 (Figures 2A–2D). Indeed, elevated levels
of Hsp104 have differential ability to cure various prions in vivo.
For example, Hsp104 overexpression cures [PSI+] but has
limited ability to cure [URE3] (Chernoff et al., 1995; Kryndushkin
et al., 2008;Moriyama et al., 2000). Yet in vitro, Hsp104 catalyzes
similar amounts of Sup35 and Ure2 prion remodeling (Shorter
and Lindquist, 2006). Importantly, however, when the in vitro
Hsp104-remodeled Sup35 and Ure2 products are compared
functionally, Sup35 products fail to seed prion assembly and
do not convert [psi] cells to [PSI+], whereas the Ure2 products
are short prion fibers with high infectivity that readily convert
[ure-o] cells to [URE3] (Shorter and Lindquist, 2006). Based on
this precedent, we hypothesized that NM4 prions that had
been remodeled by Hsp104 might retain greater seeding activity
than NM25 or NM37 prions that had been remodeled by Hsp104.
Remodeling of NM4 prions by a high concentration (1 mM) of
Hsp104 in the presence or absence of Ssa1 and Sis1 led to
increased breakage of Head and Tail contacts (Figure 3).
However, intermolecular contacts were still detectable (Figure 3).
Surprisingly, EM revealed that NM4 prions were converted to
numerous short fibers by high levels of Hsp104 (Figure 4, condi-
tions with 1 mM Hsp104). By contrast, remodeling of NM25 and
NM37 prions by a high concentration (1mM) of Hsp104, in the
presence or absence of Ssa1 and Sis1, led to more effective
disruption ofHead andTail contacts compared toNM4 (Figure 3).
Indeed, very few fibers were visible by EM after NM25 prions
were remodeled by high concentrations of Hsp104 (Figure 4,
conditions with 1 mM Hsp104). The predominant reaction0, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1403
Figure 4. Hsp104 More Readily Fragments
NM4 Prions than NM25 or NM37 Prions
NM4, NM25, or NM37 (2.5 mM monomer) were
incubated with Hsp104 (0–1 mM) in the presence or
absence of Ssa1 (2.5 mM) and Sis1 (2.5 mM) for
60min at 25C. Reactions were then processed for
electron microscopy. Note that Hsp104 (0.1 mM)
more readily fragments NM4 than NM25, and
NM37 is even more resistant to fragmentation. At
higher Hsp104 concentration (1 mM) short prion
fibers persist for NM4, but NM25 and NM37 are
remodeled into amorphous aggregated species
(arrows). Bar, 0.5 mm.
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phous structures were also observed (Figure 4, arrows; 1 mM
Hsp104). Similar types of amorphous structures were more
commonly observed after remodeling NM37 prions with high
concentrations of Hsp104 (Figure 4, arrows; 1 mM Hsp104).
Presumably, these structures can still bind ThT and retain
some SDS-resistance (Figures 2A–2D). Taken together, these
findings suggest that even at high concentrations, Hsp104
fragments NM4 into shorter and shorter fibers. By contrast,
acting at high concentrations, Hsp104 effectively disrupts the
Head and Tail contacts of NM25 and NM37 prions (Figure 3),
but simultaneously converts them into a mixture of soluble
species and alternative aggregated structures (Figure 4).
Next, we compared the self-templating activity of NM4, NM25,
and NM37 prions that had been treated with a low (0.1 mM) or
high concentration (1 mM) of Hsp104 in the presence or absence
of Ssa1 and Sis1. To do so, we used His6-Hsp104, which could
be rapidly depleted at the end of the reaction using Ni-sepharose
without codepleting NM prions (Shorter and Lindquist, 2004,
2006). After depleting His6-Hsp104, we tested the ability of the
remaining conformers to seed the polymerization of soluble
NM in vitro. In the presence of Ssa1 and Sis1, treatment with
a low concentration of Hsp104 increased the ability of NM4,
NM25, and NM37 prions to seed the polymerization of soluble
NM (Figures 5A–5C, compare dark blue to gray lines). This effect
was more pronounced for NM4 prions (Figure 5A) than for NM25
prions (Figure 5B). Indeed, treatment with a low concentration of
Hsp104 mimicked the effect of sonication for NM4 (Figure 5A,
compare black to gray lines). By contrast, the low concentration
of Hsp104 was not as effective as sonication in generating new
fiber ends for NM25 (Figure 5B, compare black to gray lines).
Hsp104 was least effective in generating new fiber ends for
NM37 (Figure 5C, compare black to gray lines). For NM4 and
NM25, we obtained very similar results if Ssa1 and Sis1 were
omitted (Figures 5D and 5E). By contrast, for NM37, treatment
with a low concentration of Hsp104 did not increase the ability
of NM37 to seed soluble NM (Figure 5F, compare dark blue
to orange lines). Thus, Ssa1 and Sis1 play a more important
role in Hsp104-catalyzed fragmentation of NM37 prions. Taken
together, these data suggest that Hsp104 more readily frag-
ments NM4 than NM25. Moreover, they suggest that NM371404 Chemistry & Biology 19, 1400–1410, November 21, 2012 ª2012 Elsevier Ltd All rights reprions are more resistant to Hsp104-
catalyzed fragmentation, and make a
more stringent requirement for Ssa1 andSis1. Thus, as cross-beta structure encroaches deeper into
C-terminal stretches of primary sequence, as with NM25 and
NM37 (Figure 1), then NM prions become more difficult for
Hsp104 to fragment.
Hsp104 Selectively Amplifies Prions that Encode
Strong [PSI+]
Next, we determined how treatment with a low concentration of
Hsp104 affected the composition of the strain distribution that
underpins the NM4 ensemble (Figure 1). Thus, we transformed
reaction products into [psi] cells (Shorter and Lindquist, 2006;
Tanaka et al., 2004). Transformation of [psi] cells with unsoni-
cated NM4 yielded a mixture of strong [PSI+] (30%), weak
[PSI+] (10%), and [psi] (60%) colonies, whereas sonicated
NM4 yielded strong [PSI+] (60%), weak [PSI+] (20%), and
[psi] (20%) (Figure 6A). Thus, sonication increased the pro-
portion of total [PSI+] colonies without affecting the strong
[PSI+]:weak [PSI+] ratio, which remained at 3:1 (Figure 6A).
By contrast, incubation of NM4 with a low Hsp104 concentration
yielded a mixture of strong [PSI+] (81%), weak [PSI+] (10%),
and [psi] (9%) colonies (Figure 6A). Thus, like sonication,
Hsp104 increased the proportion of total [PSI+] colonies.
However, in contrast to sonication, Hsp104 shifted the strong
[PSI+]:weak [PSI+] ratio to 8:1 (Figure 6A). We obtained very
similar results when Ssa1 and Sis1 were omitted, and treatment
with Ssa1 and Sis1 alone did not change the strain distribution
(Figure 6A). Thus, exposure to a low concentration of Hsp104
preferentially amplifies prions encoding strong [PSI+].
Prions that encode strong [PSI+] were also amplified upon
treating NM25 and NM37 prions with a low concentration of
Hsp104 (Figures 6B and 6C). Thus, like sonication, treatment
of NM25 prions with a low Hsp104 concentration (0.1 mM) in
the presence or absence of Ssa1 and Sis1 increased the pro-
portion of total [PSI+] colonies from 29% to 80% (Figure 6B).
For NM37, sonication increased the proportion of total [PSI+]
colonies from 20% to 60%, whereas treatment with a low
Hsp104 concentration in the presence of Ssa1 and Sis1
increased it to 31% (Figure 6C). In the absence of Ssa1 and
Sis1, treatment of NM37 with a low Hsp104 concentration only
slightly increased the proportion of total [PSI+] colonies (Fig-
ure 6C). Sonication maintained the strong [PSI+]:weak [PSI+]served
Figure 5. Hsp104 More Readily Eliminates the Seeding Activity of NM25 and NM37 Prions
(A–F) NM4, NM25, or NM37 (2.5 mMmonomer) were either left untreated, sonicated, or treated with His6-Hsp104 (0.1 or 1 mM) in the presence (A–C) or absence
(D–F) of Ssa1 (2.5 mM) and Sis1 (2.5 mM) for 60 min at 25C. Reactions were then depleted of His6-Hsp104 and used to seed (2% wt/wt) fresh, undisturbed
NM (2.5 mM) polymerization. Seeding reactions were performed at 4C for NM4 products (A and D), 25C for NM25 products (B and E), and 37C for NM37
products (C and F). Values represent means ± SEM (n = 3).
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By contrast, for both NM25 and NM37, treatment with a low
concentration of Hsp104 in the presence of Ssa1 and Sis1
shifted the strong [PSI+]:weak [PSI+] ratio toward strong [PSI+]
(Figures 6B and 6C). Specifically, Hsp104 shifted the strong
[PSI+]:weak [PSI+] ratio from 1:3 to 1:1.4 for NM25 and from
1:5 to 1:1.6 for NM37 (Figures 6B and 6C). We obtained
very similar results when Ssa1 and Sis1 were omitted for
NM25: the strong [PSI+]:weak [PSI+] ratio shifted to 1:1.2
(Figure 6B). However, for NM37, omission of Ssa1 and Sis1 led
to a smaller shift in the strong [PSI+]:weak [PSI+] from 1:5
to 1:2.2 (Figure 6C). Treatment with Ssa1 and Sis1 alone didChemistry & Biology 19, 1400–141not change the strain distribution (Figures 6B and 6C). Collec-
tively, these findings suggest that Hsp104-catalyzed prion frag-
mentation is strain selective, whereas sonication is nonspecific.
Remarkably, when NM prion strain ensembles are exposed to
low concentrations of Hsp104, prions encoding strong [PSI+]
were selectively amplified and prions encoding weak [PSI+]
were selected against.
Hsp104 Selectively Eliminates Prions that Encode
Weak [PSI+]
Next, we assessed the behavior of NM4, NM25, and NM37
prions that had been exposed to a high concentration of0, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1405
Figure 6. Hsp104 Selectively Amplifies Prions that Encode Strong [PSI+] and Selectively Eliminates Prions that Encode Weak [PSI+] In Vitro
(A–C) NM4 (A), NM25 (B), or NM37 (C) (2.5 mM monomer) were either left untreated, sonicated, or treated with His6-Hsp104 (0.1 or 1 mM) in the presence or
absence of Ssa1 (2.5 mM) and Sis1 (2.5 mM) for 60 min at 25C. Reactions were then depleted of His6-Hsp104, concentrated and transformed into [psi
] cells.
Soluble NM served as a negative control. The number of weak and strong [PSI+] colonies relative to total transformants was then determined. Values represent
means from three experiments.
(D) NM37 (2.5 mMmonomer) was either sonicated or treated with His6-Hsp104 (1 mM), Ssa1 (2.5 mM), and Sis1 (2.5 mM) for 60 min at 25
C. Reactions were then
depleted of His6-Hsp104 and used to seed (50% wt/wt) fresh, undisturbed NM (2.5 mM) polymerization at 4
C for 6 hr. Unseeded reactions served as a control.
Reaction products were concentrated, sonicated, and transformed into [psi] cells. Soluble NM served as a negative control. The number of weak and strong
[PSI+] colonies relative to total transformants was then determined. Values represent means from three experiments.
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Hsp104 Drives Sup35 Prion Strain SelectionHsp104 (1mM) in the presence of Ssa1 and Sis1 for 60 min. Here,
Hsp104 diminished the ability of NM25 and NM37 to seed the
polymerization of soluble NM in vitro (Figures 5B and 5C,
compare dark blue to green line) and diminished their ability to
transform [psi] cells to weak [PSI+] (Figures 6B and 6C). Indeed,
no weak [PSI+] colonies were recovered after treating NM37 with
high concentrations of Hsp104 (Figure 6C). Remarkably,
however, NM25 and NM37 remodeled products could still
induce some strong [PSI+] colonies (Figure 6B, C). By contrast,
the final NM4 reaction products retained a greater ability to1406 Chemistry & Biology 19, 1400–1410, November 21, 2012 ª2012seed the polymerization of soluble NM in vitro (Figure 5A,
compare dark blue and green line) and could still transform
[psi] cells to strong [PSI+], but not weak [PSI+] (Figure 6A). We
obtained very similar results when Ssa1 and Sis1 were omitted,
and treatment with Ssa1 and Sis1 alone had no effect (Figures
5D–5F and 6A–6C). These data suggest that elevated levels of
Hsp104 preferentially convert NM25 and NM37 prions, which
encode predominantly weak [PSI+], to nonprion forms, whereas
a subpopulation of remodeled NM4 products retain their strong
[PSI+] prion character. These data are sufficient to explain whyElsevier Ltd All rights reserved
Figure 7. Hsp104 Selectively Amplifies Prions that Encode Strong [PSI+] and Selectively Eliminates Prions that Encode Weak [PSI+] In Vivo
(A) NM-YFP was overexpressed for 6 hr at 30C in [psi] [PIN+] cells expressing normal (vector) or elevated (Hsp104) levels of Hsp104. Cells were plated on 25%
YPD and the proportion of [psi], weak [PSI+], and strong [PSI+] colonies was determined. Values represent means from three experiments.
(B) NM4, NM25, or NM37 were transformed into [psi] cells expressing normal (vector) or elevated levels of Hsp104 (Hsp104). The number of weak and strong
[PSI+] colonies relative to total transformants was then determined. Values represent means from three experiments.
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Hsp104 Drives Sup35 Prion Strain Selectionoverexpression of Hsp104 cures weak [PSI+] more readily than
strong [PSI+] (Chernoff et al., 1995; Wegrzyn et al., 2001),
because Hsp104-catalyzed remodeling preferentially destroys
the prion nature of NM25 and NM37 prions, but not NM4 prions.
Next, we assessed whether prions encoding strong [PSI+]
could sweep the population after treating NM37 with a high
concentration of Hsp104 for 60 min in the presence of Ssa1
andSis1. Todo so,weused a larger quantity of the reaction prod-
ucts to seed (50%wt/wt) NM assembly at 4C for 6 hr. Strikingly,
we recovered prions that encoded purely strong [PSI+] (Fig-
ure 6D). By contrast, if sonication were used instead of Hsp104
then the prion ensemble retained the original strain distribution
that was strongly biased toward weak [PSI+] (Figure 6D). Thus,
Hsp104 selectively amplifies prions that encode strong [PSI+]
and selectively eliminates prions that encode weak [PSI+].
Hsp104 Selects against Prions that Encode
Weak [PSI+] In Vivo
Finally, we corroborated these findings in vivo in two ways. First,
we induced [PSI+] by expressing high levels of NM-YFP in yeast
expressing normal or elevated levels of Hsp104. [PSI+] induction
was reduced from 26% to 5% in cells expressing high levels
of Hsp104 (Figure 7A). Strikingly, however, this effect was largely
due to a decrease in the appearance of weak [PSI+] colonies.
Indeed, the proportion of colonies that were strong [PSI+]
decreased from 6.7% in the vector control to 3.3% in cells
overexpressing Hsp104, which was not statistically significant
(p = 0.2521, two-tailed Student’s t test). By contrast, the propor-
tion of colonies that were weak [PSI+] decreased from19.3% in
the vector control to 1.7% in cells overexpressing Hsp104,
which was statistically significant (p = 0.0006, two-tailed
Student’s t test; Figure 7A). Thus, Hsp104 selectively antago-
nizes the induction of weak [PSI+] in vivo.
In a second approach, we induced [PSI+] by transforming
synthetic NM4, NM25, or NM37 prions into [psi] cells express-
ing normal or elevated levels of Hsp104. Here too, although high
levels of Hsp104 reduced [PSI+] induction, this effect was largely
due to a reduction in the proportion of weak [PSI+] colonies
(Figure 7B). Indeed, the reduction in weak [PSI+] induction
caused by Hsp104 overexpression was 4.3-fold for NM4 (p =Chemistry & Biology 19, 1400–1410.0073, two-tailed Student’s t test), 29-fold for NM25 (p <
0.0001, two-tailed Student’s t test), and 13-fold for NM37
infection (p = 0.0013, two-tailed Student’s t test), whereas the
reduction in strong [PSI+] induction was 1.6-fold for NM4
(p = 0.0033, two-tailed Student’s t test), 1.1-fold for NM25
(p = 0.5896, two-tailed Student’s t test), and 1.5-fold for
NM37 infection (p = 0.3098, two-tailed Student’s t test). Thus,
the reduction in weak [PSI+] induction caused by elevated
Hsp104 levels was statistically significant for NM4, NM25, and
NM37 infection, whereas the reduction in strong [PSI+] induction
only reached statistical significance for NM4 infection. These
data suggest that Hsp104 selects against Sup35 prions that
encode weak [PSI+] in vitro and in vivo.
DISCUSSION
To the best of our knowledge, our study represents the first
reconstitution of direct mechanisms by which the chaperone
network can drive ‘‘protein only’’ positive selection of a specific
prion strain in vitro and in vivo. Thus, we uncover that Hsp104
remodeling activity creates a positive selection pressure for
Sup35 prion strains that encode strong [PSI+]. We also assessed
how Hsp104 affects the distinct intermolecular contacts of
different synthetic Sup35 prion strains. At low concentrations,
Hsp104 more readily fragments Sup35 prion strains encoding
strong [PSI+] by breaking both Head and Tail contacts, thereby
liberating more polymerization surfaces for further confor-
mational replication. This observation suggests that the precise
Sup35 prion conformation determines the fragmentation rate
by Hsp104, which in turn makes a large contribution to deter-
mining the strength of the [PSI+]-encoded nonsense suppression
phenotype.
Unexpectedly, the increased fragmentation of prion confor-
mations that encode strong [PSI+] does not lead to increased
elimination of the prion form, even at high Hsp104 concentra-
tions. One possible explanation is that the increased number of
fiber ends breaches a threshold that converts newly liberated
soluble NM to the prion form with kinetics that keeps pace with
Hsp104-catalyzed release of soluble NM. By contrast, Hsp104
is much less able to fragment prion strains (NM25 or NM37)0, November 21, 2012 ª2012 Elsevier Ltd All rights reserved 1407
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Hsp104 Drives Sup35 Prion Strain Selectionthat encode weak [PSI+]. Indeed, acting at low concentrations
Hsp104 preferentially fragments the Tail contact of NM25 and
NM37 prions. Moreover, for NM37 prions, Ssa1 and Sis1 are
more stringently required to break the Tail contact. Conse-
quently, treatment of NM25 and NM37 prions with low Hsp104
concentrations yields fewer ends for conformational replication
compared to strains that encode strong [PSI+]. At high concen-
trations, Hsp104 converts NM25 and NM37 prions to soluble
species and non-templating amorphous aggregates, which
lack seeding activity.
Our findings also suggest that Hsp104 activity can create
a selection pressure against Sup35 prions that encode weak
[PSI+] both in vitro and in vivo. These findings help explain why
some weak [PSI+] strains spontaneously convert to strong
[PSI+] (Kochneva-Pervukhova et al., 2001). Thus, prions encod-
ing strong [PSI+] that spontaneously appear in a weak [PSI+]
strain would be rapidly and selectively amplified by Hsp104
acting even at low concentrations. Sup35 prions encoding
strong [PSI+] would then sweep the Sup35 prion population of
that cell. In this way, Hsp104 drives ‘‘protein only’’ directional
selection for Sup35 prions that encode strong [PSI+].
Unlike their mammalian counterparts, yeast prions confer
advantages to their host and enable the rapid evolution of bene-
ficial, heritable traits in response to environmental stress (Alberti
et al., 2009; Halfmann et al., 2012; Suzuki et al., 2012; True et al.,
2004; Tyedmers et al., 2008). Indeed, [PSI+], and numerous other
prions are found in natural populations of yeast (Halfmann et al.,
2012). [PSI+] induction frequency increases in response to
various environmental stresses despite elevated Hsp104
expression levels (Tyedmers et al., 2008). Our data suggest
that elevated Hsp104 concentration might help ensure the
appearance of strong [PSI+] rather than weak [PSI+] in response
to environmental stress. The appearance of strong [PSI+] would
then in turn release larger amounts of cryptic genetic variation in
a more stable, heritable manner, which could facilitate more
rapid sampling of diverse phenotypes within the population
and promote survival (Shorter, 2010; Shorter and Lindquist,
2005; True et al., 2004). Our data provide important mechanistic
insights into how prion-remodeling components of the proteo-
stasis network directly drive the Darwinian evolution of prion
strains (Li et al., 2010). An understanding of how the proteostasis
network affects the evolution of mammalian prion strain ensem-
bles is urgently needed to help combat the devastating neuro-
degenerative disorders inflicted by these evolvable infectious
agents (Collinge and Clarke, 2007; Shorter, 2010). Moreover,
the prion concept has now expanded to explain how self-
templating amyloid forms might spread in various neurodegen-
erative amyloidoses, including Alzheimer’s and Parkinson’s
disease (Cushman et al., 2010). In these cases too, it is likely
that strain phenomena are at play, and it is critical to understand
how the proteostasis network might affect strain selection
events of various self-templating amyloid forms connected to
neurodegeneration (Cushman et al., 2010; Duennwald and
Shorter, 2010; Shorter, 2010).
SIGNIFICANCE
The endogenous selection pressures within cells and
tissues that drive the amplification of one prion strain at1408 Chemistry & Biology 19, 1400–1410, November 21, 2012 ª2012the expense of another are not understood. Here, using
pure components, we define for the first time, to our knowl-
edge, the direct effects of Hsp104 on different synthetic
Sup35 prion strains, which were previously unknown.
Hsp104 more readily remodels (i.e., reduces the amount of
cross-beta structure) Sup35 prions with shorter, less stable
amyloid cores that encode strong [PSI+]. Counterintuitively,
this enhanced remodeling favors the replication of Sup35
prions that encode strong [PSI+]. We define unanticipated
differences in the way Hsp104 disrupts the intermolecular
contacts of different Sup35 prion strains. Thus, at low
concentrations, Hsp104 can effectively break Head and
Tail contacts of prions encoding strong [PSI+], but can only
break the Tail contact of prions encoding weak [PSI+].
Indeed, Hsp104 can fragment Sup35 prions by breaking the
Tail contact without remodeling cross-beta structure (i.e.,
reducing ThT fluorescence or the amount of SDS-resistant
Sup35). Ssa1 (Hsp70) and Sis1 (Hsp40) are more stringently
required for Hsp104 to break intermolecular contacts of
Sup35 prions encoding weak [PSI+]. Collectively, these find-
ings explain why particular Sup35 prion strains encode
strong [PSI+] and why others encode weak [PSI+] in vivo.
At higher concentrations, Hsp104 more effectively disrupts
the intermolecular contacts of prions encoding weak [PSI+]
by converting prions into nontemplating structures. By con-
trast, even though Hsp104 more readily fragments prions
encoding strong [PSI+] it has reduced ability to eliminate
their infectivity. These findings explain why overexpression
of Hsp104 cures weak [PSI+] more readily than strong
[PSI+] in vivo. To our knowledge, our findings represent the
first reconstitution of ‘‘protein-only’’ positive selection of
a specific prion strain by a molecular chaperone (Hsp104).
Moreover, these data have key ramifications for eliminating
deleterious, evolvable mammalian prions and other self-
templating amyloid conformers connected to devastating
neurodegenerative diseases.
EXPERIMENTAL PROCEDURES
Proteins
Hsp104, Ssa1, Sis1, and NM were purified as described (Shorter and Lind-
quist, 2004, 2006, 2008; Sweeny et al., 2011). Single cysteine NM mutants
were labeled with pyrene-maleimide (Invitrogen) under denaturing conditions
as described (Krishnan and Lindquist, 2005). The purity of all proteins was
>95% as determined by SDS-PAGE and Coomassie staining. Hsp104 con-
centrations refer to the hexamer concentration.
Prion Assembly
NM (5 mM) fibers were assembled in Assembly Buffer (AB: 40mMHEPES-KOH
pH 7.4, 150 mM KCl, 20 mM MgCl2, and 1mM dithiothreitol [DTT]) for 16 hr
with agitation (1,400 rpm in an Eppendorf Thermomixer) at 4C to yield NM4,
at 25C to yield NM25, or at 37C to yield NM37 (Roberts et al., 2009).
All fiber preparations were assessed by Thioflavin-T (ThT) fluorescence,
SDS-resistance, and electron microscopy (Chernoff et al., 2002; Shorter and
Lindquist, 2004, 2006). Fibers were diluted to the requisite concentration for
subsequent remodeling reactions. Alternatively, NM proteins (5 mM) carrying
pyrene labels at the indicated single cysteine were assembled at 4C, 25C,
or 37C with agitation for 12 hr.
Prion Remodeling
NM4, NM25, or NM37 (2.5 mM) were incubated with increasing concentrations
of Hsp104 (0.001–25 mM) in the presence or absence of Ssa1 (2.5 mM) andElsevier Ltd All rights reserved
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Hsp104 Drives Sup35 Prion Strain SelectionSis1 (2.5 mM) for 60 min at 25C in AB in the presence of ATP (5 mM) and an
ATP regeneration system (1 mM creatine phosphate, 0.25 mM creatine kinase
[Roche]). Fiber integrity was then determined by ThT fluorescence, SDS-
resistance, or electron microscopy (Chernoff et al., 2002; Shorter and Lind-
quist, 2004, 2006). To monitor intermolecular prion contacts, we employed
NM prions labeled with pyrene at the indicated single cysteine as described
(Krishnan and Lindquist, 2005). Pyrene excimer fluorescence was measured
as described (Krishnan and Lindquist, 2005).
Hsp104:NM Prion Binding
Due to rapid ATP hydrolysis, Hsp104 engages substrates transiently. Thus, to
assess Hsp104:NM prion binding interactions we employed conditions were
ATP hydrolysis was restricted. Thus, we employed wild-type Hsp104 in the
presence of ATPgS (1 mM). Increasing amounts of Hsp104 were incubated
with NM4, NM25, or NM37 (0.5 mM monomer) in AB for 10 min on ice. NM4,
NM25, or NM37 were then rapidly recovered by centrifugation at 100,000 g
for 10 min. Pellets were washed gently twice with binding buffer and the
amount of Hsp104 recovered in the pellet fraction was determined by quanti-
tative immunoblot and densitometry in comparison to Hsp104 reference
curves.
Seeded NM Assembly Reactions
NM4, NM25, or NM37 (2.5 mMmonomer) in ABwere either left untreated, soni-
cated, or treated with His6-Hsp104 (0.1 or 1 mM), Ssa1 (2.5 mM), and Sis1
(2.5 mM) for 60 min at 25C as above. Reactions were then depleted of His6-
Hsp104 as described (Shorter and Lindquist, 2004) and used to seed (2%
wt/wt) fresh, undisturbed NM (2.5 mM) polymerization in seeding buffer
(40mMHEPES-KOHpH7.4, 150mMNaCl, 1mMDTT, 20mMEDTA). Seeding
reactions were performed at 4C for NM4 products, 25C for NM25 products,
and 37C for NM37 products (in Figure 5). Alternatively (for Figure 6D), NM37
(2.5 mM monomer) in AB was either left untreated, sonicated, or treated with
His6-Hsp104 (1 mM), Ssa1 (2.5 mM), and Sis1 (2.5 mM) for 60min at 25
C. Reac-
tions were then depleted of His6-Hsp104 as described (Shorter and Lindquist,
2004) and used to seed (50% wt/wt) fresh, undisturbed NM (2.5 mM) polymer-
ization at 4C for 6 hr in seeding buffer. Owing to the transience of Hsp104-
substrate interactions, NM conformers are not codepleted with Hsp104
(Shorter and Lindquist, 2004, 2006).
NM Prion Transformation
Yeast cells from a W303-derived strain (MATa leu2-3, 112 his3-11 trp1-1
ura3-1 ade1-14 can1-100 [pin] [psi] [ure-o]) that contained an ADE1
nonsense mutation suppressible by [PSI+] were transformed with the
indicated NM conformers and a URA3 plasmid as described (Krishnan and
Lindquist, 2005; Shorter and Lindquist, 2006). The proportion of Ura+ trans-
formants that acquired weak or strong [PSI+] was then determined. In some
experiments (Figure 7B), the [psi] yeast cells harbored a plasmid carrying
HSP104 under the control of a galactose-inducible promoter or an empty
vector control. In this case, cells were grown in selective SGal media prior
to transformation. Thus, as soon as the synthetic prions entered the cyto-
plasm they are exposed to high levels of Hsp104. Immediately after prion
transformation, cells were plated on SD-ura media to switch off expression
from the HSP104 plasmid.
[PSI+] Induction
Yeast cells from a W303-derived strain (MATa leu2-3, 112 his3-11 trp1-1
ura3-1 ade1-14 can1-100 [PIN+] [psi] [ure-o]) were transformed with a
plasmid that encoded NM-YFP under the control of a galactose-inducible
promoter and either an empty vector control or a plasmid with HSP104
under the control of a galactose-inducible promoter. Cells were grown in
selective liquid medium containing raffinose as sole carbon source overnight.
The next day, the yeast cells were washed three times with sterile water
before transferring them to selective liquid media containing galactose as
the sole carbon source. The cells were incubated in the galactose media
for 6 hr at 30C before they were diluted to an OD600 of 0.002 and evenly
plated on 25% YPD plates. The proportion of red ([psi] colonies), white
(strong [PSI+] colonies), and pink (weak [PSI+] colonies) ADE+ colonies was
then determined.Chemistry & Biology 19, 1400–141ACKNOWLEDGMENTS
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